1211 / 1816
➢
HER2
- Surexpression in 20-25% of BC
(Spector et al., J Clin Oncol 2009)
- Trastuzumab
(Piccart-Gebhart et al., N Engl J Med 2005,
Halyard et al., J Clin Oncol 2009)
- Association RT & Trastuzumab
>
radio sensibilisation
(Pietras et al., Cancer Res 1999)
Toxicity?